Pfizer's Monthly GLP-1 Obesity Injection Shows Competitive Promise
#pfizer #obesity #glp1 #pf_08653944 #pharma
Pfizer's PF-08653944 shows promising monthly dosing with notable weight loss in the VESPER-3 trial and a competitive edge over weekly injections.
